Keros Therapeutics, Inc. (KROS)
11.02
+0.03
(+0.27%)
USD |
NASDAQ |
Mar 13, 16:00
11.00
-0.02
(-0.14%)
After-Hours: 20:00
Keros Therapeutics Total Liabilities (Quarterly) : 39.74M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| MannKind Corp. | 843.20M |
| Sarepta Therapeutics, Inc. | 2.209B |
| PTC Therapeutics, Inc. | 3.117B |
| Insmed, Inc. | 1.526B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 342.87M |
| Shareholders Equity (Quarterly) | 303.13M |
| Debt to Equity Ratio | 0.0557 |
| Current Ratio | 15.45 |
| Net Debt Paydown Yield | 0.12% |